George E. MacDougall is currently the Head of Investor Relations at REGENXBIO Inc., where they contribute to advancing the company's gene therapy innovations. With previous experience as Senior Director of Investor Relations at Gritstone bio and Director at MacDougall, George has demonstrated a strong commitment to supporting biotechnology companies in achieving their objectives. They have served on the Board of NIRI Boston Chapter since 2024 and have managed various investor relations and corporate communications roles throughout their career. George holds an MBA from Drexel University and a degree in Strategic Communications and Political Science from Miami University.
Location
Boston, United States
This person is not in any teams
This person is not in any offices